These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10616187)
41. [Laboratory for the control of serum vaccines and other biological products]. M'Henni A Arch Inst Pasteur Tunis; 1997; 74(1-2):129-33. PubMed ID: 15945193 [No Abstract] [Full Text] [Related]
42. [Brief introduction of the construction of legal system of traditional Chinese medicine in modern China]. Li Z; Lu ZL Zhonghua Yi Shi Za Zhi; 2007 Oct; 37(4):218-21. PubMed ID: 19127846 [TBL] [Abstract][Full Text] [Related]
43. The need for FDA regulation of tobacco products. Kennedy EM Yale J Health Policy Law Ethics; 2002; 3(1):101-8. PubMed ID: 12825428 [No Abstract] [Full Text] [Related]
44. WHO technical report series 200 (1960). Pittman M Dev Biol Stand; 1974; 23():182-4. PubMed ID: 4459194 [No Abstract] [Full Text] [Related]
45. Current regulatory and legal considerations for follow-on biologics. Kingham RF; Lietzan E Clin Pharmacol Ther; 2008 Nov; 84(5):633-5. PubMed ID: 18716615 [No Abstract] [Full Text] [Related]
46. Legal developments relevant to FDA authority. Meron D Food Drug Law J; 2007; 62(2):441-4. PubMed ID: 17632974 [No Abstract] [Full Text] [Related]
47. International Conference on Harmonisation; guidance on quality of biotechnological/biological products: derivation and characterization of cell substrates used for production of biotechnological/biological products; availability. Notice. Food and Drug Administration, HHS. Fed Regist; 1998 Sep; 63(182):50244-9. PubMed ID: 12269373 [TBL] [Abstract][Full Text] [Related]
48. International acceptance of blood and blood products. Petricciani JC Dev Biol (Basel); 2000; 102():3-8. PubMed ID: 10794085 [TBL] [Abstract][Full Text] [Related]
49. Recent progress on the total synthesis of natural products in China. Wu Q; Ma D Nat Prod Rep; 2006 Oct; 23(5):772-88. PubMed ID: 17003909 [TBL] [Abstract][Full Text] [Related]
50. Product traceability and lookback: assuring the integrity of the transfusion process. Flanagan P Dev Biol (Basel); 2007; 127():225-33. PubMed ID: 17486896 [No Abstract] [Full Text] [Related]
51. Worldwide perspective in transfusion safety: Europe. Reesink HW; Strengers PE Dev Biol (Basel); 2000; 102():205-10. PubMed ID: 10794107 [No Abstract] [Full Text] [Related]
57. Informed consent and living human cells. Maloney DM Hum Res Rep; 2002 Jul; 17(7):3. PubMed ID: 12731490 [No Abstract] [Full Text] [Related]
58. Regulating health care markets in China and India. Bloom G; Kanjilal B; Peters DH Health Aff (Millwood); 2008; 27(4):952-63. PubMed ID: 18607028 [TBL] [Abstract][Full Text] [Related]
59. A pilot survey of community health services in China. Klink K; Lin SX Fam Med; 2008 Oct; 40(9):615-6. PubMed ID: 18830831 [No Abstract] [Full Text] [Related]